Luis Fernando Nagano (Luis F P Nagano)

Years Active: 2023-2024
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Verena Silva Santos, Gabriela Maciel Vieira, Mariana Tannús Ruckert, Pamela Viani de Andrade, Luis Fernando Nagano, Mariângela Ottoboni Brunaldi, José Sebastião Dos Santos, Vanessa Silva Silveira
Atypical phosphatase DUSP11 inhibition promotes nc886 expression and potentiates gemcitabine-mediated cell death through NF-kB modulation. Cancer gene therapy (2024)
Graziella Ribeiro de Sousa, Karina B Salomão, Luis Fernando Nagano, Kent A Riemondy, Pablo S Chagas, Luciana C Veronez, Fabiano P Saggioro, Suely K N Marie, José A Yunes, Izilda A Cardinalli, Silvia R Brandalise, Rosane G de Paula Queiroz, Carlos Alberto Scrideli, Andrew M Donson, Nicholas K Foreman, Luiz G Tone, Elvis Terci Valera
Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas. Cancer gene therapy (2023)

Luis Fernando Nagano.css-eqlu8i{font-size:small;padding-left:4px;} (Luis F P Nagano)